Literature DB >> 30134417

ACOG Practice Bulletin No. 198 Summary: Prevention and Management of Obstetric Lacerations at Vaginal Delivery.

.   

Abstract

Lacerations are common after vaginal birth. Trauma can occur on the cervix, vagina, and vulva, including the labial, periclitoral, and periurethral regions, and the perineum. Most of these lacerations do not result in adverse functional outcomes. Severe perineal lacerations, extending into or through the anal sphincter complex, although less frequent, are more commonly associated with increased risk of pelvic floor injury, fecal and urinary incontinence, pain, and sexual dysfunction with symptoms that may persist or be present many years after giving birth. The purpose of this document is to provide evidence-based guidelines for the prevention, identification, and repair of obstetric lacerations and for episiotomy.

Entities:  

Mesh:

Year:  2018        PMID: 30134417     DOI: 10.1097/AOG.0000000000002842

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  A novel classification for evaluating episiotomy practices: application to the Burgundy perinatal network.

Authors:  Thomas Desplanches; Emilie Szczepanski; Jonathan Cottenet; Denis Semama; Catherine Quantin; Paul Sagot
Journal:  BMC Pregnancy Childbirth       Date:  2019-08-16       Impact factor: 3.007

Review 2.  Pelvic Floor Dysfunction After Hysterectomy: Moving the Investigation Forward.

Authors:  Valerie Chen; Laura Shackelford; Marta Spain
Journal:  Cureus       Date:  2021-06-15

3.  Mediolateral episiotomy and risk of obstetric anal sphincter injuries and adverse neonatal outcomes during operative vaginal delivery in nulliparous women: a propensity-score analysis.

Authors:  Thomas Desplanches; Laetitia Marchand-Martin; Emilie-Denise Szczepanski; Marie Ruillier; Jonathan Cottenet; Denis Semama; Emmanuel Simon; Catherine Quantin; Paul Sagot
Journal:  BMC Pregnancy Childbirth       Date:  2022-01-19       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.